Yarrow Bioscience, Inc. (YARW)
40.50
+1.25
(+3.18%)
USD |
NASDAQ |
Aug 26, 11:22
Yarrow Bioscience Shareholders Equity (Quarterly) : 22.06M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.06M |
| March 31, 2026 | 24.64M |
| December 31, 2025 | 27.76M |
| September 30, 2025 | 32.09M |
| June 30, 2025 | 38.88M |
| March 31, 2025 | 44.13M |
| December 31, 2024 | 52.09M |
| September 30, 2024 | 63.54M |
| June 30, 2024 | 74.87M |
| March 31, 2024 | 83.37M |
| December 31, 2023 | 88.74M |
| September 30, 2023 | 11.50M |
| June 30, 2023 | 17.27M |
| March 31, 2023 | 26.43M |
| December 31, 2022 | 31.41M |
| September 30, 2022 | 40.07M |
| June 30, 2022 | 48.36M |
| March 31, 2022 | 55.73M |
| December 31, 2021 | 48.64M |
| September 30, 2021 | 58.89M |
| Date | Value |
|---|---|
| June 30, 2021 | 74.89M |
| March 31, 2021 | 92.90M |
| December 31, 2020 | 37.49M |
| September 30, 2020 | 49.52M |
| June 30, 2020 | 71.53M |
| March 31, 2020 | 69.54M |
| December 31, 2019 | 17.58M |
| September 30, 2019 | 87.00M |
| June 30, 2019 | 102.18M |
| March 31, 2019 | 115.63M |
| December 31, 2018 | 130.38M |
| September 30, 2018 | 146.88M |
| June 30, 2018 | 158.19M |
| March 31, 2018 | 165.70M |
| December 31, 2017 | 52.29M |
| September 30, 2017 | 61.37M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 29.56M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 317.47M |
| NRX Pharmaceuticals, Inc. | -0.17M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.60M |
| Total Liabilities (Quarterly) | 1.542M |
| Current Ratio | 15.26 |
| Net Debt Paydown Yield | 0.06% |